In 2022, Recipharm reported a total of 1,828,439 ton CO₂e, and a net revenue of 1,293 M USD, resulting in a emissions intensity of 1,414 t CO₂e / M USD.
Base year:
2021
Target year:
2030
Reduction:
0.42
Classification:
1.5°C
Recipharm commits to reduce absolute scope 1 and 2 GHG emissions 42.1% by 2030 from a 2021 base year*. *The target boundary includes land-related emissions and removals from bioenergy feedstocks.
Source: Science Based Target initative
Emissions, Revenue & Intensity
Emissions, Target & Trend
Emissions Overview | 2021 | 2022 |
Total Emissions - Market Based (t CO₂e) | 1,697,115 | 1,828,439 |
---|---|---|
Emissions Intensity (t CO₂e / M USD) | 1,402 | 1,414 |
Cradle-to-gate Intensity (t CO₂e / M USD) |